Cleverbase Selects Verimatrix Code Shield for Strong Cybersecurity Read more about Cleverbase Selects Verimatrix Code Shield for Strong Cybersecurity
Q-Free: Acceptances received under mandatory offer to acquire all shares in Q-Free ASA Read more about Q-Free: Acceptances received under mandatory offer to acquire all shares in Q-Free ASA
GEVELOT S.A.: Weekly report of share buyback November 29, 2022 Read more about GEVELOT S.A.: Weekly report of share buyback November 29, 2022
HERIGE finalizes its acquisition of PORALU Group and becomes one of the leading French manufacturers of industrial joinery Read more about HERIGE finalizes its acquisition of PORALU Group and becomes one of the leading French manufacturers of industrial joinery
MaaT Pharma To Webcast Investor Meeting in Conjunction with ASH 2022 Conference Read more about MaaT Pharma To Webcast Investor Meeting in Conjunction with ASH 2022 Conference
Lysogene Provides Updates and Topline Results from Phase 2/3 AAVance Gene Therapy Clinical Study Read more about Lysogene Provides Updates and Topline Results from Phase 2/3 AAVance Gene Therapy Clinical Study
Pherecydes Pharma Announces the Positive Recommendation of the DSMB For the Continuation of Its Phase II Clinical Study PhagoDAIR in Osteoarticular Infections Caused by Staphylococcus aureus Read more about Pherecydes Pharma Announces the Positive Recommendation of the DSMB For the Continuation of Its Phase II Clinical Study PhagoDAIR in Osteoarticular Infections Caused by Staphylococcus aureus
SII : Résultats du premier semestre de l’exercice 2022/2023 Read more about SII : Résultats du premier semestre de l’exercice 2022/2023
Valneva to Host Investor Day in New York City Read more about Valneva to Host Investor Day in New York City